See more : KRAFTON, Inc. (259960.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Japan Tobacco Inc. (JAPAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Japan Tobacco Inc., a leading company in the Tobacco industry within the Consumer Defensive sector.
You may be interested
- United Alloy-Tech Company (3162.TWO) Income Statement Analysis – Financial Results
- Zhongchang Big Data Corporation Limited (600242.SS) Income Statement Analysis – Financial Results
- GFJ ESG Acquisition I SE (GFJ1.DE) Income Statement Analysis – Financial Results
- Cinese International Group Holdings Limited (1620.HK) Income Statement Analysis – Financial Results
- Africa Energy Corp. (HPMCF) Income Statement Analysis – Financial Results
Japan Tobacco Inc. (JAPAF)
About Japan Tobacco Inc.
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,841.08B | 2,657.83B | 2,324.84B | 2,092.56B | 2,175.63B | 2,215.96B | 2,139.65B | 2,143.29B | 2,252.88B | 2,019.75B | 2,120.20B | 2,033.83B | 6,194.55B | 6,134.70B | 6,832.31B | 6,409.73B | 4,769.39B | 4,637.66B | 4,664.51B | 4,625.15B | 4,492.26B | 4,544.18B |
| Cost of Revenue | 1,225.97B | 1,090.99B | 956.86B | 898.00B | 942.30B | 933.03B | 843.56B | 872.43B | 920.06B | 822.54B | 899.39B | 892.03B | 5,074.07B | 5,022.64B | 5,554.40B | 5,228.93B | 3,844.77B | 3,734.07B | 3,713.73B | 3,684.01B | 3,569.39B | 3,598.80B |
| Gross Profit | 1,615.10B | 1,566.84B | 1,367.98B | 1,194.56B | 1,233.33B | 1,282.93B | 1,296.10B | 1,270.85B | 1,332.83B | 1,197.21B | 1,220.80B | 1,141.79B | 1,120.48B | 1,112.06B | 1,277.91B | 1,180.80B | 924.62B | 903.58B | 950.79B | 941.14B | 922.87B | 945.38B |
| Gross Profit Ratio | 56.85% | 58.95% | 58.84% | 57.09% | 56.69% | 57.89% | 60.58% | 59.29% | 59.16% | 59.28% | 57.58% | 56.14% | 18.09% | 18.13% | 18.70% | 18.42% | 19.39% | 19.48% | 20.38% | 20.35% | 20.54% | 20.80% |
| Research & Development | 0.00 | 70.81B | 65.02B | 60.85B | 64.08B | 65.38B | 60.60B | 58.19B | 57.80B | 58.68B | 56.86B | 51.46B | 51.46B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 981.05B | 941.54B | 888.57B | 784.47B | 831.71B | 770.41B | 786.91B | 754.12B | 789.35B | 752.56B | 733.39B | 27.92B | 791.80B | 815.55B | 914.10B | 750.25B | 592.63B | 596.64B | 677.42B | 707.10B | 733.91B | 781.57B |
| Selling & Marketing | 0.00 | 233.37B | 204.84B | 177.02B | 191.03B | 188.06B | 218.03B | 228.53B | 224.10B | 255.18B | 199.20B | 190.50B | 218.42B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 981.05B | 941.54B | 888.57B | 784.47B | 831.71B | 770.41B | 786.91B | 754.12B | 789.35B | 752.56B | 733.39B | 218.42B | 791.80B | 815.55B | 914.10B | 750.25B | 592.63B | 596.64B | 677.42B | 707.10B | 733.91B | 781.57B |
| Other Expenses | -38.36B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -5.74B | -47.58B | 0.00 | 0.00 | 0.00 | 0.00 | -53.11B | 0.00 | -77.75B |
| Operating Expenses | 942.69B | 921.28B | 872.95B | 729.55B | 735.98B | 721.88B | 741.19B | 684.01B | 773.98B | 752.56B | 691.22B | 563.49B | 791.80B | 815.55B | 914.10B | 750.25B | 592.63B | 596.64B | 677.42B | 707.10B | 733.91B | 781.57B |
| Cost & Expenses | 2,168.67B | 2,012.27B | 1,829.81B | 1,627.55B | 1,678.28B | 1,654.91B | 1,584.75B | 1,556.45B | 1,694.04B | 1,575.10B | 1,590.61B | 1,455.53B | 5,865.87B | 5,838.19B | 6,468.50B | 5,979.17B | 4,437.40B | 4,330.71B | 4,391.14B | 4,391.12B | 4,303.30B | 4,380.37B |
| Interest Income | 44.41B | 31.15B | 19.01B | 12.35B | 8.40B | 5.75B | 4.78B | 6.62B | 15.02B | 13.81B | 5.49B | 5.60B | 3.03B | 6.98B | 12.28B | 13.41B | 13.41B | 12.10B | 0.00 | 3.24B | 3.24B | 4.70B |
| Interest Expense | 95.22B | 91.27B | 45.65B | 61.34B | 45.53B | 39.25B | 27.35B | 21.71B | 15.13B | 11.16B | 28.29B | 23.43B | 17.06B | 26.11B | 51.36B | 41.76B | 6.94B | 5.78B | 5.15B | 8.14B | 8.55B | 10.27B |
| Depreciation & Amortization | 179.65B | 199.37B | 187.00B | 179.29B | 183.32B | 158.10B | 144.84B | 140.15B | 139.06B | 122.17B | 116.46B | 118.85B | 212.76B | 230.20B | 282.41B | 171.54B | 132.64B | 126.45B | 126.74B | 153.59B | 148.33B | 170.31B |
| EBITDA | 824.78B | 836.31B | 673.86B | 661.06B | 694.61B | 680.32B | 711.29B | 740.74B | 719.30B | 635.86B | 789.53B | 654.17B | 583.63B | 529.15B | 532.36B | 595.91B | 585.91B | 429.78B | 433.21B | 337.76B | 296.42B | 299.38B |
| EBITDA Ratio | 29.03% | 33.27% | 30.33% | 31.59% | 31.93% | 32.92% | 33.24% | 34.56% | 31.93% | 29.13% | 30.86% | 34.55% | 8.79% | 8.61% | 8.94% | 8.58% | 9.34% | 9.27% | 9.82% | 7.30% | 6.60% | 5.75% |
| Operating Income | 672.41B | 653.58B | 499.02B | 469.05B | 502.36B | 564.98B | 561.10B | 593.33B | 565.23B | 466.27B | 532.36B | 408.62B | 328.68B | 296.51B | 363.81B | 430.55B | 312.90B | 306.95B | 273.37B | 234.03B | 148.08B | 163.81B |
| Operating Income Ratio | 23.67% | 24.59% | 21.46% | 22.42% | 23.09% | 25.50% | 26.22% | 27.68% | 25.09% | 23.09% | 25.11% | 20.09% | 5.31% | 4.83% | 5.32% | 6.72% | 6.56% | 6.62% | 5.86% | 5.06% | 3.30% | 3.60% |
| Total Other Income/Expenses | -50.81B | -60.13B | -26.63B | -48.99B | -37.12B | -33.50B | -22.57B | -15.09B | -116.00M | 57.88B | -12.06B | -22.86B | -10.29B | 56.56B | -20.45B | 8.81B | -57.94B | 5.21B | -5.95B | -132.70B | -241.64B | -21.31B |
| Income Before Tax | 621.60B | 593.45B | 472.39B | 420.06B | 465.23B | 531.49B | 538.53B | 578.24B | 565.11B | 502.53B | 509.56B | 441.36B | 280.50B | 276.06B | 262.14B | 372.61B | 337.20B | 300.99B | 101.33B | -7.61B | 142.50B | 98.24B |
| Income Before Tax Ratio | 21.88% | 22.33% | 20.32% | 20.07% | 21.38% | 23.98% | 25.17% | 26.98% | 25.08% | 24.88% | 24.03% | 21.70% | 4.53% | 4.50% | 3.84% | 5.81% | 7.07% | 6.49% | 2.17% | -0.16% | 3.17% | 2.16% |
| Income Tax Expense | 136.29B | 149.28B | 132.21B | 108.03B | 103.61B | 144.06B | 141.78B | 152.46B | 162.39B | 132.81B | 158.04B | 112.80B | 130.89B | 131.30B | 134.97B | 128.38B | 121.41B | 94.90B | 31.57B | -4.81B | 61.81B | 56.73B |
| Net Income | 482.29B | 442.72B | 338.49B | 310.25B | 348.19B | 385.68B | 392.41B | 421.70B | 485.69B | 362.92B | 343.61B | 320.88B | 144.96B | 138.45B | 123.40B | 238.70B | 210.77B | 201.54B | 62.58B | -7.60B | 75.30B | 36.85B |
| Net Income Ratio | 16.98% | 16.66% | 14.56% | 14.83% | 16.00% | 17.40% | 18.34% | 19.68% | 21.56% | 17.97% | 16.21% | 15.78% | 2.34% | 2.26% | 1.81% | 3.72% | 4.42% | 4.35% | 1.34% | -0.16% | 1.68% | 0.81% |
| EPS | 271.63 | 249.45 | 190.76 | 174.88 | 195.97 | 215.31 | 219.10 | 235.47 | 270.54 | 199.67 | 181.07 | 168.50 | 75.71 | 72.26 | 64.40 | 124.58 | 110.01 | 105.19 | 32.23 | -3.97 | 37.53 | 18.43 |
| EPS Diluted | 271.63 | 249.36 | 190.68 | 174.80 | 195.87 | 215.20 | 218.97 | 235.33 | 270.37 | 199.56 | 180.99 | 168.44 | 75.68 | 72.24 | 64.40 | 124.58 | 110.01 | 105.19 | 32.23 | -3.97 | 37.53 | 18.43 |
| Weighted Avg Shares Out | 1.78B | 1.77B | 1.77B | 1.77B | 1.78B | 1.79B | 1.79B | 1.79B | 1.80B | 1.82B | 1.90B | 1.90B | 1.91B | 1.92B | 1.92B | 1.92B | 1.92B | 1.92B | 1.94B | 1.92B | 2.01B | 2.00B |
| Weighted Avg Shares Out (Dil) | 1.78B | 1.78B | 1.78B | 1.77B | 1.78B | 1.79B | 1.79B | 1.79B | 1.80B | 1.82B | 1.90B | 1.91B | 1.92B | 1.92B | 1.92B | 1.92B | 1.92B | 1.92B | 1.94B | 1.92B | 2.01B | 2.00B |
Japan Tobacco Inc. (JAPAY) Q3 2024 Earnings Call Transcript
Japan Tobacco Inc. (JAPAY) Q3 2024 Earnings Call Transcript
Japan Tobacco: The Vector Group Acquisition Impact
Japan Tobacco Inc.'s YTD gains are unsurprising, given its muted profit outlook, high market multiples, and lower dividend yield compared to peers even towards the start of the year. Its recent acquisition of Vector Group raises concerns further about Japan...
Japan Tobacco: It's All About The Yen (Rating Downgrade)
JAPAY's Q2 2024 top line grew by +14.0% YoY and exceeded the consensus projection by +4.6%, thanks to the weakening of the Japanese yen. But it is likely that the Japanese yen could strengthen going forward, and this means that...
Japan Tobacco Inc. (JAPAF) Q4 2023 Earnings Call Transcript
Japan Tobacco Inc. (JAPAF) Q4 2023 Earnings Call Transcript
Japan Tobacco Inc. (JAPAF) Q3 2023 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q3 2023 Earnings Conference Call October 31, 2023 4:00 AM ET Company Participants Hiromasa Furukawa - CFO Conference Call Participants Hiroshi Saji - Mizuho Securities Satoshi Fujiwara - Nomura Securities Makoto Morita - Daiwa Securities Haruka...
Japan Tobacco: Accelerating Growth Justifies A Higher Valuation
Japan Tobacco faces challenges due to regulations and growing awareness of health risks, but the tobacco market continues to grow. New Zealand plans to implement a lifetime ban on tobacco purchasing for young people, but it is unlikely to have...
Japan Tobacco Inc. (JAPAF) Q2 2023 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q2 2023 Earnings Conference Call July 31, 2023 4:00 AM ET Company Participants Nobuya Kato - Chief Financial Officer Koji Shimayoshi - JTI Deputy Chief Executive Officer Conference Call Participants Haruka Miyake - Morgan Stanley Hiroshi...
E-cig startup Juul is talking to Philip Morris, Altria, and Japan Tobacco about its future, WSJ reports. Here's a rundown of the startup's rise and fall.
Juul rebranded three times, sold assets, and attracted nontraditional investors. Now, it's reportedly in partnership talks with big tobacco companies.
Japan Tobacco Inc. (JAPAF) Q1 2023 Earnings Call Transcript
Japan Tobacco Inc. (OTCPK:JAPAF) Q1 2023 Earnings Conference Call May 2, 2023 4:00 AM ET Company Participants Nobuya Kato - Chief Financial Officer Koji Shimayoshi - JTI, Deputy Chief Executive Officer Conference Call Participants Hiroshi Saji - Mizuho Securities Satoshi...
If I Could Only Buy 2 Dividend Stocks In April 2023
In today's article, I will introduce you to my two top dividend picks of the month, which I currently consider attractive due to various factors. Both companies have strong financial health, possess important competitive advantages and their valuation is currently...
Source: https://incomestatements.info
Category: Stock Reports